about
Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisExtra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 yearsRheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control studyAutoimmune valvular carditisThe role of circulating fibrocytes in inflammation and autoimmunityCardiorheumatology: cardiac involvement in systemic rheumatic diseaseA role for methotrexate in the management of non-infectious orbital inflammatory diseaseAssociation of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritisCardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritisMultiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapyHigh-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammationCXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritisThe cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasionThe vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphologyPropensity-adjusted association of methotrexate with overall survival in rheumatoid arthritisCardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study.Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association database.A systematic review of studies comparing health outcomes in Canada and the United States.Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients.Rheumatoid factor, chronic arthritis and mortality.Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls?Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapiesIncidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.Why do people with rheumatoid arthritis still die prematurely?Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women's Health StudyMortality trends in rheumatoid arthritis: the role of rheumatoid factorCost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management.Autoantibodies and the risk of cardiovascular events.Treatment of rheumatoid arthritis with traditional chinese medicine.Review article: safety of infliximab in clinical trials.Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patientsValidating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.Biologics and heart failure in rheumatoid arthritis: are we any wiser?Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.[Factors associated with infection in rheumatoid arthritis].Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study.
P2860
Q24242787-E31FE2ED-EBEF-4DB5-892B-41D44D2DF300Q24674079-05BFCED0-AC45-45A0-86A8-6EE477367475Q24812262-8562E8B3-F939-4561-B0AD-F825BD19BEA6Q26825666-246A4E4E-7D03-4CE8-9B58-98DCA340B7F1Q26829700-B5AD9EDF-CC4B-4406-82F4-7F73D63D9920Q27008927-6BF1C7C7-8113-4A90-9AE6-7587E3D97565Q28360294-A3CD4ED0-FE47-4B73-907A-D1133C0E6330Q28386085-89C80629-FEFE-461C-9FC2-99EF97FB9B11Q28390163-52AB205E-23E4-49C6-905B-05215AB36BEFQ28475972-DD999AFB-8AEA-450B-93F4-F126D0C84DB1Q28480869-44CF2832-6262-446A-9B24-9AF131C5A2C4Q28569526-A03D8BBA-1D19-4FBD-AAC2-9AB580B7CDA3Q28573570-7325A493-91A4-4B3E-873C-5625A9CBCC93Q28577203-3B0AEEEE-3DDD-420F-A614-DFC107B4E88FQ28709376-AA309C98-68C9-4943-A03A-14CF8524ED77Q30275864-6AC868E2-C51B-4F22-A314-8969CD29DCEFQ33478325-3BCC9029-8CD5-4F63-928B-466866122314Q33529391-8274B4DF-EF81-41FC-9AF1-8A8216AD7101Q33572563-38E67099-2AA5-40AA-A2EB-2CC8FD6BB238Q33578306-A032EE00-120C-4D27-8F40-4F3189811851Q33578403-FD45A6DF-BA32-41B1-8ABC-15AE2093BCC9Q33579327-D20A9480-76C2-4299-AD73-12C7BABC9FE6Q33579891-604243F6-FEFB-49B3-ABB7-6B314F9034D0Q33602465-4E42ED69-35A6-4D2A-85B6-168EBA21802BQ33629320-93E67D9A-4973-473D-8300-DB75289367EBQ33637906-EC9C0B65-EFC1-41DC-80B0-B0A90F71B5B4Q33697879-1DBC9119-7DAE-4234-B01C-A3F729A6BC52Q33706873-3D7F4871-122B-452E-98DE-B3D0590EB65EQ33709660-411093DD-42B0-4226-B0E6-B05BEA04E483Q33717053-F50A55D6-0CBD-4F2A-8475-DF8E47B4D5E6Q33721605-A7DD2302-A07D-4E68-8F76-5163811FC495Q33786655-1DFEC5A4-949C-4411-B0CE-FDAA3CF1CD7CQ33793931-0B4B57F3-57AB-4C1F-82EC-45BA86F17EEFQ33865776-25AAA4BE-BF3C-44AB-AB3C-7C58CA610FF4Q33893290-05FE5DCB-E6DD-4980-8F9F-302AEBC04728Q33898103-EFFD1577-513A-4623-B7D8-905915BE47F3Q33910329-ADCC7353-C505-4507-A16E-22AC5B0A689EQ33962865-881D99BD-F58B-4A49-B9F9-149304C4C9E8Q34019646-90AA8612-240F-468C-9160-CD469F3C23C1Q34082035-39D5F8CD-1D17-4E57-A08D-5013FAB16525
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
The mortality of rheumatoid arthritis.
@ast
The mortality of rheumatoid arthritis.
@en
The mortality of rheumatoid arthritis.
@nl
type
label
The mortality of rheumatoid arthritis.
@ast
The mortality of rheumatoid arthritis.
@en
The mortality of rheumatoid arthritis.
@nl
prefLabel
The mortality of rheumatoid arthritis.
@ast
The mortality of rheumatoid arthritis.
@en
The mortality of rheumatoid arthritis.
@nl
P2093
P356
P1476
The mortality of rheumatoid arthritis.
@en
P2093
Kleinheksel SM
Mitchell DM
Williams CA
P304
P356
10.1002/ART.1780370408
P577
1994-04-01T00:00:00Z